NMC-CBT Medicines Management and Pharmacology Flashcards
7 cards from real NMC CBT practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 NMC-CBT Medicines Management and Pharmacology flashcards as text
A patient is receiving a continuous IV infusion of heparin. Which laboratory test is used to monitor its therapeutic effect?
Answer: APTT (Activated Partial Thromboplastin Time)
APTT is the standard monitoring test for unfractionated heparin therapy, with a therapeutic target typically 1.5–2.5 times the control value.
A patient with type 1 diabetes is nil by mouth before surgery. What is the most appropriate action regarding their insulin?
Answer: Continue long-acting insulin and start a variable rate IV insulin infusion
Patients with type 1 diabetes require basal insulin even when fasting; a variable rate IV insulin infusion (VRIII) should be commenced perioperatively.
Which of the following is the antidote for paracetamol overdose?
Answer: Acetylcysteine (N-acetylcysteine)
N-acetylcysteine (Parvolex) replenishes glutathione stores and prevents hepatotoxicity caused by paracetamol overdose.
A nurse is preparing to give an intramuscular injection of metoclopramide. Which site is most commonly used for IM injections in adults?
Answer: Ventrogluteal site
The ventrogluteal site is now the preferred IM injection site in adults due to fewer major blood vessels and nerves, lower infection risk, and larger muscle mass.
What does a 'black triangle' symbol (▼) on a medication mean in the UK?
Answer: The medication is subject to additional monitoring by the MHRA
The black triangle indicates that the medicine is subject to additional monitoring, and healthcare professionals and patients are encouraged to report all suspected side effects.
A patient prescribed lithium complains of coarse tremor, vomiting, and confusion. What should the nurse suspect?
Answer: Lithium toxicity
Coarse tremor, vomiting, and confusion are classic signs of lithium toxicity, which requires immediate cessation and urgent medical review.
When administering eye drops, how far should the dropper be held from the eye to prevent contamination and injury?
Answer: 1–2 cm
The dropper should be held approximately 1–2 cm above the lower conjunctival sac to avoid touching the eye and contaminating the bottle.